Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To study and compare acceptability and tolerance between breast-feeding post-partum woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving birth, using either Levonorgestrel or Etonogestrel contraceptive implant.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Levonorgestrel immediate post-partum | Experimental | Breast-feeding postpartum woman who receive Levonorgestrel drug implant (75 mg) between 48-72 hr after child delivery |
|
| Etonogestrel immediate post-partum | Experimental | Breast-feeding postpartum woman who receive Etonogestrel drug implant (68 mg) between 48-72 hr after child delivery |
|
| Levonorgestrel delayed post-partum | Active Comparator | Breast-feeding postpartum woman who receive Levonorgestrel drug implant (75 mg) between 5-7 weeks after child delivery |
|
| Etonogestrel delayed post-partum | Active Comparator | Breast-feeding postpartum woman who receive Etonogestrel drug implant (68 mg) between 5-7 weeks after child delivery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Etonogestrel Drug Implant | Drug | Etonogestrel 68 mg (single rod) is implanted at inner arm of participant. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with treatment-related adverse events | To compare treatment-related adverse events between Immediate and delayed breastfeeding postpartum contraceptive users, using case record form which specify bleeding days, spotting days, abdominal discomfort, headache, acne, alopecia, weight and blood pressure of users. | immediately after contraceptive implant use until 12 weeks after use |
| Removal rate of contraceptive implants users | To compare tolerance between Immediate and delayed breastfeeding postpartum contraceptive users, by collecting and calculating removal rate of users. | immediately after contraceptive implant use until 12 weeks after use |
| Satisfactory of contraceptive implant users | To compare acceptability between Immediate and delayed breastfeeding postpartum contraceptive users, using questionnaire rating satisfactory scale by score from 1 to 5 | immediately after contraceptive implant use until 12 weeks after use |
| Measure | Description | Time Frame |
|---|---|---|
| Breastfeeding status | To compare breastfeeding status between Immediate and delayed breastfeeding postpartum contraceptive users by using questionnaire whether each participant is full-breastfeeding, partial-breastfeeding or non-breastfeeding and specify reasons if she's not full-breastfeeding. | immediately after contraceptive implant use until 12 weeks after use |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Unnop Jaisamrarn, M.D. | Chulalongkorn University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| King Chulalongkorn Memorial Hospital | Pathum Wan | Bangkok | 10330 | Thailand |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36302159 | Derived | Sothornwit J, Kaewrudee S, Lumbiganon P, Pattanittum P, Averbach SH. Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception. Cochrane Database Syst Rev. 2022 Oct 27;10(10):CD011913. doi: 10.1002/14651858.CD011913.pub3. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001942 | Breast Feeding |
| ID | Term |
|---|---|
| D005247 | Feeding Behavior |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| C044815 | etonogestrel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Levonorgestrel Drug Implant | Drug | Levonorgestrel 75 mg (2 rods) are implanted at inner arm of participant. |
|
|
| Child weight | To compare child growth by measuring weight, between Immediate and delayed breastfeeding postpartum contraceptive users. | immediately after contraceptive implant use until 12 weeks after use |
| Child height | To compare child growth by measuring height, between Immediate and delayed breastfeeding postpartum contraceptive users. | immediately after contraceptive implant use until 12 weeks after use |